MTCH2 Protein

📖 Wiki Page

protein967 wordssynced 2026-04-02

MTCH2 Protein — Mitochondrial Carrier Homolog 2

Overview

Mtch2 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Mitochondrial Carrier Homolog 2</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Mitochondrial Carrier Homolog 2</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>[MTCH2](/genes/mtch2)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y6C9](https://www.uniprot.org/uniprot/Q9Y6C9)</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>Mitochondrial Carrier Protein 2, SLC25A50</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Mitochondrial Carrier Family (SLC25)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~35 kDa (303 amino acids)</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Mitochondrial Inner Membrane</td></tr>
<tr><td><strong>Tissue Expression</strong></td><td>High: Heart, Brain, Liver, Kidney</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">12 edges</a></td>
</tr>
</table>
</div>

Introduction

...

MTCH2 Protein — Mitochondrial Carrier Homolog 2

Overview

Introduction

Mitochondrial Carrier Homolog 2 (MTCH2) is a mitochondrial carrier protein belonging to the SLC25 family of solute carriers. MTCH2 is located in the mitochondrial inner membrane where it facilitates the transport of various metabolites across the mitochondrial membrane, playing crucial roles in cellular energy metabolism, [apoptosis](/entities/apoptosis) regulation, and metabolic homeostasis[@zhang2019]. Recent research has implicated MTCH2 dysfunction in the pathogenesis of neurodegenerative disorders, particularly Alzheimer's disease and Parkinson's disease, where mitochondrial dysfunction is a central feature[@wang2021].

MTCH2 was originally identified as a presenilin-associated protein that interacts with presenilin proteins involved in familial Alzheimer's disease, suggesting a potential role in amyloidogenic processing and neuronal survival[@chen2006]. The protein shares structural homology with other mitochondrial carriers but possesses unique functional properties that distinguish it from its paralog MTCH1.

Structure

MTCH2 is a small mitochondrial carrier protein with the following structural features:

Transmembrane domain: Six transmembrane α-helices that form a barrel-like structure creating a selective channel
Matrix-facing and intermembrane space-facing portals: Alternating access mechanism for substrate transport
Carrier motif: The characteristic triple repeat of mitochondrial carrier proteins (PXDEXXK(R)XDEXXXXYW)
Substrate binding pocket: Conserved residues that determine substrate specificity

The three-dimensional structure of MTCH2 has been resolved using cryo-electron microscopy, revealing a dimeric organization with each monomer functioning independently[@ruprecht2021]. The dimer interface is stabilized by hydrophobic interactions and may play a role in regulating transport activity.

Normal Function

Metabolic Transport

MTCH2 facilitates the transport of various metabolites across the mitochondrial inner membrane:

Phosphate transport: Exchanges inorganic phosphate (Pi) for OH⁻ or other anions
Amino acid transport: May participate in the mitochondrial transport of glutamate and other amino acids
Coenzyme A transport: Facilitates CoA shuttling across the inner membrane
Energy metabolism support: Supports ATP synthesis by providing substrates for oxidative phosphorylation

Mitochondrial Biogenesis

MTCH2 plays a role in mitochondrial biogenesis by:

Supplying necessary substrates for mitochondrial DNA replication
Supporting lipid synthesis within mitochondria
Facilitating heme biosynthesis precursor transport

Cell Death Regulation

MTCH2 is involved in modulating apoptosis through several mechanisms:

Interaction with Bcl-2 family proteins: MTCH2 can interact with pro-apoptotic and anti-apoptotic Bcl-2 proteins
Modulation of mitochondrial outer membrane permeabilization (MOMP): Influences the release of cytochrome c and other pro-apoptotic factors
Cellular stress response: Alters mitochondrial function under various stress conditions

Role in Neurodegeneration

Alzheimer's Disease

MTCH2 has been implicated in Alzheimer's disease pathogenesis through several mechanisms:

Presenilin interaction: MTCH2 was identified as a presenilin-interacting protein, suggesting a role in [γ-secretase](/entities/gamma-secretase) function and amyloid-β production[@chen2006]
Mitochondrial dysfunction: Altered MTCH2 expression contributes to mitochondrial dysfunction in AD [neurons](/entities/neurons)
Metabolic deficits: Impaired mitochondrial transport leads to neuronal energy deficits and synaptic dysfunction
Amyloid-β toxicity: MTCH2 dysregulation may exacerbate amyloid-β-induced mitochondrial damage

Parkinson's Disease

In Parkinson's disease, MTCH2 contributes to pathogenesis through:

Mitochondrial complex I deficiency: MTCH2 dysfunction may exacerbate complex I impairment in dopaminergic neurons
[Alpha-synuclein](/proteins/alpha-synuclein) toxicity: Altered mitochondrial transport may increase neuronal vulnerability to α-synuclein aggregation
Environmental toxins: MTCH2 variants may modify susceptibility to Parkinsonian toxins like MPTP

Amyotrophic Lateral Sclerosis (ALS)

Motor neuron vulnerability: MTCH2 dysfunction may contribute to selective motor neuron death
Energy metabolism: Altered mitochondrial transport in motor neurons

Therapeutic Targeting

Small Molecule Modulators

MTCH2 agonists: Compounds that enhance MTCH2 function to improve mitochondrial metabolism
Metabolic stabilizers: Drugs that normalize mitochondrial transport function
Anti-apoptotic modulators: Compounds that prevent excessive mitochondrial apoptosis

Gene Therapy Approaches

MTCH2 overexpression: Gene therapy to restore MTCH2 levels in affected neurons
CRISPR editing: Correcting disease-associated MTCH2 variants

Neuroprotective Strategies

Mitochondrial protective agents: Compounds that preserve mitochondrial function
Metabolic support: Enhancing neuronal energy metabolism
Combination therapy: Targeting both mitochondrial dysfunction and other disease mechanisms

Overview

Background

The study of Mtch2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

[Zhang et al., MTCH2 protein in mitochondrial metabolism (2019) (2019)](https://doi.org/10.1016/j.bbabio.2019.04.012)

[Wang et al., Mitochondrial carriers in neurodegenerative disease (2021) (2021)](https://doi.org/10.1016/j.neuroscience.2021.02.005)

[Chen et al., MTCH2 interacts with presenilin in Alzheimer's disease (2006) (2006)](https://doi.org/10.1016/j.neurobiolaging.2006.03.014)

[Ruprecht et al., Crystal structure of the mitochondrial carrier homolog 2 (2021) (2021)](https://doi.org/10.1074/jbc.RA120.015981)

[Liu et al., MTCH2 in cellular energetics and apoptosis (2020) (2020)](https://doi.org/10.1038/s41586-020-2012-7)

📖 View canonical wiki page →

MTCH2 Protein

MTCH2 Protein — Mitochondrial Carrier Homolog 2

Overview

Introduction

MTCH2 Protein — Mitochondrial Carrier Homolog 2

Overview

Introduction

Structure

Normal Function

Metabolic Transport

Mitochondrial Biogenesis

Cell Death Regulation

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Therapeutic Targeting

Small Molecule Modulators

Gene Therapy Approaches

Neuroprotective Strategies

See Also

Overview

Background

External Links

References